MyCelx Technologies Corporation

AGM Information • Sep 23, 2025

National Storage Mechanism | Additional information

RNS Number : 5085A

MyCelx Technologies Corporation

23 September 2025

23 September 2025

MYCELX Technologies Corporation

("MYCELX" or the "Company") (AIM: MYX or MYXR)

Result of Annual Meeting

The Company is pleased to announce that, at its Annual Meeting held on 23 September 2025 at the offices of Cavendish Capital Markets Limited, One Bartholomew Close, London EC1A 7BL, the resolutions set out in the Notice of Annual Meeting were duly passed on a Poll.

Full details of the resolutions passed are set out in the Notice of Meeting which is available on the Company's website www.mycelx.com .

Resolutions	For / Discretion		Against		Total	Vote withheld*
Number	%	Number	%
1A To elect Tom Lamb as a Director	12,965,359	100.00	-	-	12,965,359	-
1B To elect Connie Mixon as a Director	12,965,359	100.00	-	-	12,965,359	-
1C To elect Haluk (Hal) Alper as a Director	12,965,359	100.00	-	-	12,965,359	-
1D To elect Andre Schnabl as a Director	12,965,359	100.00	-	-	12,965,359	-
2. Ratification of appointment of BDO USA P.C.as independent registered public accounting firm	12,965,359	100.00	-	-	12,965,359	-

*'Vote withheld' is not a vote in law and is not counted in the calculation of the proportion of the votes 'For' and 'Against' a resolution.

For further information please contact:

MYCELX TECHNOLOGIES CORPORATION Connie Mixon, CEO Kim Slayton, CFO	Tel: +1 888 306 6843
CAVENDISH CAPITAL MARKETS LIMITED (NOMINATED ADVISER AND SOLE BROKER) Giles Balleny / Callum Davidson (Corporate Finance) Harriet Ward (Corporate Broking) Jasper Berry / Michael Johnson (Sales)	Tel: +44 20 7220 0500
CELICOURT COMMUNICATIONS (FINANCIAL PR) Mark Antelme Jimmy Lea Charlie Denley-Myerson	Tel: +44 20 7770 6424

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGPKNBPPBKDFCB